Category Incontinence

Results after sacral nerve stimulation for chronic constipation.

Date: March 12, 2020
By: echo_wpbaycrest_admin
Categories: Incontinence

Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada

Date: September 23, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

Date: September 23, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

Additional Resources

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

The neural control of micturition

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

The efficacy and tolerability of the Beta 3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

Development of a core set of outcome measures for OAB treatment

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

2012 Update: Guidelines for Adult Urinary Incontinence Collaborative Consensus Document for the Canadian Urological Association

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence

Flexible-Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double-Blind, Placebo- Controlled Study of Fesoterodine in an Aging Population Trial

Date: May 6, 2018
By: echo_wpbaycrest_admin
Categories: Incontinence